Article
Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: comparison with B-type natriuretic peptide.
Division of Cardiology, Department of Medicine and Geriatrics, Kochi Medical School, Kochi, Japan.
Journal of Cardiology (impact factor:
1.28).
07/2009;
53(3):361-7.
DOI:10.1016/j.jjcc.2008.12.012
pp.361-7
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy.
[show abstract] [hide abstract]
ABSTRACT: The impact of matrix metalloproteinase (MMP) on left ventricular (LV) remodeling and heart failure events is unresolved in patients with hypertrophic cardiomyopathy (HCM). Plasma levels of MMP-2, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 and clinical findings and heart failure events were evaluated in 41 HCM patients, including 8 with LV systolic impairment. Plasma B-type natriuretic peptide (BNP) levels were also measured. MMP-2 levels in patients with severe symptoms were higher than that in those with no or mild symptoms. The levels of MMP-2 and TIMP-1 were positively related to LV end-systolic and left atrial dimensions, and inversely related to LV ejection fraction. MMP-2 levels were positively related to BNP levels (r=0.52, P=0.0009). However, MMP-9 levels were not related to echocardiographic parameters and plasma BNP levels. Six patients had complicated heart failure events during the follow-up period of 3.2+/-0.7 years. Patients with high plasma MMP-2 levels (>1,170 ng/ml) revealed a poorer prognosis than those with low MMP-2 levels. Elevated levels of MMP-2 were related to LV remodeling and poor prognosis in patients with HCM. These results suggest that regulation of the extracellular collagen matrix might be one of the therapeutic targets in patients with HCM.Circulation Journal 05/2010; 74(6):1191-6. · 3.77 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
31 patients
Average peak VO(2)
BNP levels
cardiopulmonary exercise tests
diastolic function
E/A ratio
exercise capacity
functional status
hypertrophic cardiomyopathy
lateral E/E(a)
left ventricular diastolic function
NYHA class
objective exercise capacity
plasma B-type natriuretic peptide
plasma BNP level
plasma BNP levels
Recent reports
systolic impairment
tissue Doppler imaging
transmitral flow